Salvatore T.
- Country
- Italy
- Department
- SC Oncologia Clinica e Sperimentale dei Sarcomi e dei Tumori Rari
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Phase 3 Trial of Octreotide Subcutaneous Depot vs. Octreotide LAR or Lanreotide ATG in Unresectable/Metastatic GEP-NET Patients
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
Data & Insights
Has run more than one trial at 88 of 209 partner sites.
Specializations
Sarcoma Research
This investigator specializes in various types of soft tissue sarcomas, with particular focus on treating dedifferentiated liposarcoma and leiomyosarcoma. Their research encompasses both localized and metastatic disease states.
- Advanced Soft Tissue Sarcomas
- Metastatic Leiomyosarcoma
- Pediatric Bone Sarcomas
- Tenosynovial Giant Cell Tumors
Their work includes investigating novel therapeutic approaches for Ewing Sarcoma and osteosarcoma in children and young adults.
Neuroendocrine Tumors
The investigator has extensive experience in treating gastroenteropancreatic neuroendocrine tumors and thoracic neuroendocrine tumors.
- GEP-NET Treatment Strategies
- Lung and Thymus NETs
- Well-differentiated NETs
Their research includes innovative therapeutic approaches for both early-stage and advanced neuroendocrine tumors.
Gastrointestinal Oncology
The investigator focuses on treating gastrointestinal stromal tumors (GIST) with particular attention to cases involving specific genetic mutations.
- Advanced GIST
- KIT Mutation-Specific Treatments
- Second-line Therapeutic Strategies
Their expertise includes managing complex cases of treatment-resistant gastrointestinal tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.